10x Genomics (TXG) Net Income towards Common Stockholders (2018 - 2026)
10x Genomics recorded quarterly Net Income towards Common Stockholders of -$13.5 million in Q1 2026, up 17.12% quarter-over-quarter from -$16.3 million in Q4 2025, and up 60.8% year-over-year from -$8.4 million in Q1 2025.
10x Genomics' Net Income towards Common Stockholders history runs 9 years deep, the most recent figure standing at -$13.5 million for Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders rose 60.8% year-over-year to -$13.5 million; the TTM figure through Mar 2026 stood at -$22.7 million (up 85.57% YoY), while the FY2025 annual figure was -$43.5 million, up 76.16% from the prior year.
- Net Income towards Common Stockholders came in at -$13.5 million for Q1 2026 at 10x Genomics, up from -$16.3 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $34.5 million in Q2 2025 to a low of -$93.0 million in Q3 2023.
- A 5-year average of -$38.9 million and a median of -$41.9 million in 2022 frame the typical range for Net Income towards Common Stockholders.
- Across the five-year window, Net Income towards Common Stockholders plunged 483.22% in 2022 and soared 191.14% in 2025, its largest moves.
- 10x Genomics' Net Income towards Common Stockholders stood at -$17.2 million in 2022, then slumped by 184.36% to -$49.0 million in 2023, then declined by 0.16% to -$49.0 million in 2024, then soared by 66.85% to -$16.3 million in 2025, then gained by 17.12% to -$13.5 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$13.5 million, -$16.3 million, and -$27.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.29 Bn | 27.22 Bn | 1.98 Bn | 411.00 Mn |
| 2 | Veeva Systems | 26.21 Bn | 19.65 Bn | 622.47 Mn | 244.20 Mn |
| 3 | BrightSpring Health Services | 11.98 Bn | 11.10 Bn | 482.22 Mn | 74.33 Mn |
| 4 | Healthequity | 7.59 Bn | 7.27 Bn | 228.15 Mn | 49.74 Mn |
| 5 | Hinge Health | 4.34 Bn | 4.03 Bn | 154.23 Mn | 34.01 Mn |
| 6 | Waystar Holding | 3.75 Bn | 3.59 Bn | 268.04 Mn | 43.32 Mn |
| 7 | Doximity | 3.73 Bn | 2.98 Bn | 125.97 Mn | 19.11 Mn |
| 8 | 10x Genomics | 3.04 Bn | 2.50 Bn | 106.18 Mn | -13.47 Mn |
| 9 | Privia Health | 2.83 Bn | 2.46 Bn | 595.71 Mn | 3.71 Mn |
| 10 | Omnicell | 2.01 Bn | 1.84 Bn | 140.36 Mn | 11.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.47 Mn |
| Dec 31, 2025 | -16.25 Mn |
| Sep 30, 2025 | -27.47 Mn |
| Jun 30, 2025 | 34.54 Mn |
| Mar 31, 2025 | -34.36 Mn |
| Dec 31, 2024 | -49.03 Mn |
| Sep 30, 2024 | -35.75 Mn |
| Jun 30, 2024 | -37.90 Mn |
| Mar 31, 2024 | -59.95 Mn |
| Dec 31, 2023 | -48.95 Mn |
| Sep 30, 2023 | -92.99 Mn |
| Jun 30, 2023 | -62.41 Mn |
| Mar 31, 2023 | -50.75 Mn |
| Dec 31, 2022 | -17.22 Mn |
| Sep 30, 2022 | -41.91 Mn |
| Jun 30, 2022 | -64.46 Mn |
| Mar 31, 2022 | -42.41 Mn |
| Dec 31, 2021 | -18.45 Mn |
| Sep 30, 2021 | -17.17 Mn |
| Jun 30, 2021 | -11.05 Mn |
| Mar 31, 2021 | -11.55 Mn |
| Dec 31, 2020 | -415.57 Mn |
| Sep 30, 2020 | -65.85 Mn |
| Jun 30, 2020 | -40.17 Mn |
| Mar 31, 2020 | -21.14 Mn |
| Dec 31, 2019 | -7.14 Mn |
| Sep 30, 2019 | -9.60 Mn |
| Jun 30, 2019 | -10.88 Mn |
| Mar 31, 2019 | -3.64 Mn |
| Dec 31, 2018 | -75.52 Mn |
| Sep 30, 2018 | -15.35 Mn |